The greatest innovations in retinal surgery have been technological. One example is the trocars developed within the past 20 years that eliminate retinal holes and vitreous incarceration at sclerotomy sites. The latest advances comprise 3-D surgery, intraoperative optical coherence tomography (OCT), new stains, instrumentation that consists of smaller-gauge, disposable advanced technology, and advanced vitrectomy probes, said Audina Berrocal, MD, a professor of clinical ophthalmology at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine in Miami, Florida.

Intraoperative OCT facilitates operations needed during gene therapy, such as detaching the retina and injecting viral vectors under the retina. The Finesse Flex Loop (Alcon) is retractable and acts as a scraper to remove the hyaloid membrane. If the hyaloid membrane does not remove easily with the vitrector, one may use the flex loop at the optic nerve or at the fovea. Once the hyaloid membrane has been removed, Berrocal shortens the loop and uses it as a pick. Berrocal said the instrument has a consistent contact profile in contrast to earlier versions. It is open in the middle, so that as one scrapes, one visualizes the retina.

The loop also can be used as a lasso. Berrocal said that in a demonstration, a physician used the loop to capture a cyst through a retinotomy. She said she has used this instrument to remove intraocular foreign bodies and under the retina to remove proliferative vitreoretinopathy bands. A new stain, TissueBlue (DORC), was approved recently by the FDA. This stain is heavy and deposits easily on the macula. The product is packaged premixed in individual syringes, in contrast to indocyanine green (ICG), which has to be mixed in the operating room. The premixed stain eliminates potential toxicity or mistakes associated with the mixing of the stain before use. The Finesse Sharkskin forceps (Alcon) is a new instrument for peeling of delicate internal limiting membranes that easily grasps tissue because of rough edges at the tips that facilitate easy elevation, Berrocal said. Perfluorocarbon is not new, but is the best stabilizer of giant retinal tears and serves as an aid to identifying retinal holes that are difficult to find. Berrocal showed a small 27-gauge surgery (Alcon) performed on a patient with Marfan syndrome in which the lens was subluxated. During a vitrectomy, the vitrector is used to aspirate the lens in the capsular bag. This small instrument allows elegant techniques to be performed more readily. DORC has developed a 27-gauge vitrector for infants’ eyes and smaller-diameter trocars. One asset of this kit is that it is sutureless, contrary to the Alcon 25-gauge short.

The small-gauge surgery with a beveled tip to the vitrector and 3-D viewing system have new cutters that perform 20,000 cuts per minute. The tip also allows the surgeon to be extremely close to the retina to perform difficult dissections of tractional retinal detachments without damaging the retina. Berrocal said ophthalmology is a field full of innovations. “Vitreoretinal surgeons are constantly pushing for new technologies,” she said. “Industry is key for innovations in our field, and our relationship with industry is important to bring our ideas to fruition. The technology that we have is great, but can always be better.”

Media contact:

Williams

Managing Editor

Journal of Clinical and Experimental Ophthalmology

Mail ID: opthalmology@peerjournal.org

WhatsApp no: + 1-504-608-2390